<DOC>
	<DOCNO>NCT00921362</DOCNO>
	<brief_summary>Patients eligible entry study diagnosis schizophrenia define Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSM-IV ) criterion chronic sub-chronic nature.The primary purpose study observe symptom change 6 month schizophrenia patient treat Seroquel ; additionally disease severity treatment compliance follow</brief_summary>
	<brief_title>Seroquel ( Quetiapine Fumarate ) InPractice Evaluation Programme</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>To assess baseline treatment administration severity illness patient schizophrenia , use score obtain application CGI scale To assess change symptoms patient treat Seroquel 24 week , use BPRS ( Brief Psychiatry Rating Scale ) measure tool All patient know hypersensitivity Seroquel /quetiapine excipients include study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>